Characteristics and viral propagation properties of a new human diploid cell line, walvax-2, and its suitability as a candidate cell substrate for vaccine production

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 4, 2015, Pages 998-1009

  Ma, Bo ^a,b   He, Li Fang ^b   Zhang, Yi Li ^b   Chen, Min ^b   Wang, Li Li ^b   Yang, Hong Wei ^b   Yan, Ting ^b   Sun, Meng Xiang ^a   Zheng, Cong Yi ^a  

^a WUHAN UNIVERSITY   (China)

^b Yunnan Walvax Biotech Co Ltd   (China)

Author keywords

Biological characteristics; Cell substrate; Human diploid cell strain (HDCSs); Human diploid cell vaccines (HDCVs); Viral sensitivities

Indexed keywords

DIPLOID CELL VACCINE; DNA FRAGMENT; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; VACCINE;

ARTICLE; CARCINOGENICITY; CELL GROWTH; CELL PROLIFERATION; CELL TRANSFER; CELL VIABILITY; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CRYOPRESERVATION; DIPLOIDY; GROWTH RATE; HEPATITIS A VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN ANALYSIS; RABIES VIRUS; SENSITIVITY ANALYSIS; SHORT TANDEM REPEAT; VACCINE PRODUCTION; VARICELLA ZOSTER VIRUS; VIRUS TITRATION; WALVAX 2; BIOSYNTHESIS; CELL LINE; PROCEDURES; VIRUS CULTURE;

CELL LINE; DIPLOIDY; HUMANS; VACCINES; VIRUS CULTIVATION;

EID: 84945175692     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2015.1009811     Document Type: Article

References (41)

1. Wahala WM, Silva AM. The human antibody response to dengue virus infection. Viruses 2011; 3 12:2374-95; PMID: 22355444; http://dx. doi. org/10. 3390/v3122374
2. Ciupe SM, Ribeiro RM, Perelson AS. Antibody responses during hepatitis B viral infection. PLoS Comput Biol 2014; 10 7:e1003730; PMID: 25078553; http://dx. doi. org/10. 1371/journal. pcbi. 1003730
3. WHO study group on cell substrates for production of biologicals. WHO Headquarters, 2007; 11-12, Geneva, Switzerland
4. Zhang DL, Ji L, Li LJ, Huang GS. Systematically experimental investigation on carcinogenesis or tumorigenicity of VERO cell lines of different karyotypes in nude mice in vivo used for viral vaccine manufacture. Yi Chuan Xue Bao 2004; 31 7:647-60; PMID: 15473315
5. Pagano JS, Bottiger, M, Bonnevier, JO, Gard, S. The response and the lack of spread in swedish school children given an attenuated poliovirus vaccine prepared in a human diploid cell strain. Am J Hyg 1964; 79:74-85; PMID: 14114357
6. Fletcher MA, Hessel L, Plotkin SA. Human diploid cell strains (HDCS) viral vaccines. Dev Biol Stand 1998; 93 97-107; PMID: 9737384
7. Hayflick L. History of cell substrates used for human biological. Dev Biol Stand 1989; 70:11-26; PMID: 2668070
8. Jacobs JP, Jones CM, Baille JP. Characteristics of a human diploid cell designated MRC-5. Nature 1970; 227 5254:168-70; PMID: 4316953; http://dx. doi. org/ 10. 1038/227168a0
9. Guo SH, Tao H, Ying ZF. Study on safety and immunogenicity of oral poliomyelitis attenuated live vaccine (human diploid cell). Zhongguo Yi Miao He Mian Yi 2010; 16 3:193-6; PMID:20726255
10. WHO. Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks 2010 WHO Expert Committee on Biological Standardization Geneva, World Health Organization, In press (Adopted). 2010
11. Zhang K, Na T, Wang L, Gao Q, Yin W, Wang J, Yuan BZ. Human diploid MRC-5 cells exhibit several critical properties of human umbilical cord-derived mesenchymal stem cells. Vaccine 2014;32(50):6820- 6827; PMID: 25086263
12. Yang E, Cheng C, Zhang Y, Wang J, Che Y, Pu J, Dong C, Liu L, He Z, Lu S, et al. Comparative study of the immunogenicity in mice and monkeys of an inactivated CA16 vaccine made from a human diploid cell line. Hum Vaccin Immunother 2014; 10(5):1266- 1273; PMID:24583556; http://dx. doi. org/10. 4161/ hv. 28083
13. Guo YZ, Zhou Y. The effects of environmental pollution on human chromosome instability. Proc Clinical Med J 2003; 12 12:912-3
14. von Seefried A, Chun JH. Serially subcultivated cells as substrates for poliovirus production for vaccine. Dev Biol Stand 1981; 47:25-33; PMID: 6262151
15. Leiva R. A brief history of human diploid cell strains. Natl Cathol Bioeth Q 2006; 6 3:443-51; PMID: 17091551; http://dx. doi. org/10. 5840/ncbq20066328
16. World Health Organization. Rabies Vaccines. WHO Position Paper, Weekly Epidemiological Record, No. 85, 6th August 2010, Geneva, Switzerland
17. Fang HH. Current activities of varicella vaccine in china. Conference About Quality Control of Live Attenuated Viral Vaccine. 2006 18-19, Shanghai, China
18. WHO. Recommendation for the evaluation of animal cell culture as substrates for manufacture of biological medicine products and for the characterization of cell banksIn: WHO expert committee on biological standardization. Sixty-First Report. 2013 Annex 3. In WHO Technical Report Series No. 978 World Health Organization, Geneva
19. FDA. Guidance for Industry:"Characterization and Qualification of cell Substrates and other biological materials used in the production of viral vaccines for infectious disease Indications". 2010
20. Sudarshan MK, Bhardwaj S, Mahendra BJ, Sharma H, Sanjay TV, Ashwathnarayana DH, Bilagumba G. An immunogenicity, safety and post-marketing surveillance of a novel adsorbed human diploid cell rabies vaccine (rabivax) in indian subjects. Hum Vaccin 2008; 4 4:275-9; PMID: 18682695; http://dx. doi. org/10. 4161/ hv. 4. 4. 5588
21. WHO. WHO Expert Consultation on Rabies, First Report, Technical Report Series, 931, 2005, Geneva, Switzerland
22. Tang Q, Li H. Epidemic situation and related factors analysis of rabies in China. Chin J Epidemiol 2005; 26: 223-224
23. http://www. chp. org. cn/cms/business/biological/000064. html
24. Qian H, Yu W, Liu Y, Dou ZY, Du XL, Wang Q. Studies on side effect and immunological effect of CTN-1V stain. China Public Health 2002; 18:946-7
25. He LF, Chen M, Zhang YL, Reng ZY, Hu C, Gao XZ, Zhao ZX, Ma W, Li B, Bai M. Adaption and passage rabies virus strain CTN-1V in human diploid cell strain walvax-2. Prog in Microbiol Immunol 2014;42(5):1-4
26. Yan ZL, Han XJ, Ji YJ, Song ZZ, Yu YX. Studies on the passage and adaptation of a rabies street virus in mice brain and human diploid cell strain. Chin J Microbiol Immunol 1983, 3 5:305-307
27. Dong GM, Liu ZS, Yu YX, Yan ZL, Liu JH. Studies of adaptation and passage on rabies virus (CTN-1) strain in vero cell culture. Prog in Microbiol Immunol 1995; 23 2:82-4
28. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974; 2 7892:1288-90; PMID: 4139526; http://dx. doi. org/10. 1016/S0140- 6736(74)90144-5
29. Chen EJ, Ma B, Wei SZ. The study on adaptation of hepatitis a virus YN5 strain in vero cell. Prog in Microbiol Immunol 2003; 31:1-4
30. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25 585- 621; PMID: 13905658; http://dx. doi. org/10. 1016/ 0014-4827(61)90192-6
31. Coburn SP, Leykauf RB. Human Chromosome Analysis Biokit. Burlington, NC: Carolina Biological Supply Co, 1976
32. Kong Y, LI J, An Q, Yang LH, Liu WX, Dong GM. Reverse transcriptase assay of biological products. J Microbiol 2003; 2: 005
33. Chang A, Ostrove JM, Bird RE. Development of an improved product enhanced reverse transcriptase assay. J Virol Methods 1997; 65 1:45-54; PMID: 9128861; http://dx. doi. org/10. 1016/S0166-0934(96)02168-4
34. Wiktor TJ, Fernandes MV, Koprowski H. Cultivation of rabies virus in human diploid cell strain WI-38, J Immunol 1964; 93:353-66; PMID: 14218592
35. Smith JS, Yager PA, Baer GM: A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ 1973; 48:535-41; PMID: 4544144
36. Grose C, Brunel PA. Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32°C. Infect Immun 1978; 19 1:199-203; PMID: 203532
37. Rager-Zisman B, Merigan TC. A useful quantitative semi-micromethod for viral plaque assay. Proc Soc Exp Biol Med 1973; 142:1174-9; PMID: 4121080; http:// dx. doi. org/10. 3181/00379727-142-37202
38. Grose C, Perrotta DM, Brunell PA, Smith GC. Cellfree varicella-zoster virus in cultured human melanoma cells. J Gen Virol 1979; 43 1:15-27; PMID: 225414; http://dx. doi. org/10. 1099/0022-1317-43-1-15
39. Wang ZQ, Ma L, Gao H, Dong XG. Propagation of hepatitis a virus in human diploid fibroblast cells. acta virol 1986; 30 6:463-7; PMID: 2881456
40. Wang KQ, Nielsen CM, Vestergaard BF. Isolation and adaptation characteristics of hepatitis a virus in primary african green monkey kidney cells: production of antigen useful for ELISA serology. Intervirology 1985; 24 2:99-107; PMID: 2997078; http://dx. doi. org/ 10. 1159/000149625
41. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol 1938; 27:493-7